β-N-Acetylglucosaminidase

β-N-Acetylglucosaminidase

The β-N-Acetylglucosaminidase (β-NAG) Activity Fluorometric Assay is a highly sensitive method designed to measure the enzymatic activity of β-NAG, a lysosomal hydrolase critical to cellular degradation pathways. This enzyme plays a pivotal role in the breakdown of glycoconjugates and is expressed across multiple tissues such as the kidneys, liver, lungs, and mast cells. Elevated levels of β-NAG have been associated with various pathological conditions, including Tay-Sachs and Sandhoff diseases, inflammatory responses, and immune dysfunction. Given its diagnostic and research significance, monitoring β-NAG activity can provide valuable insight into the state of lysosomal function and overall cellular health.

This assay utilizes the non-fluorescent substrate 4-Methylumbelliferyl N-acetyl-β-D-glucosaminide (4-MUAG), which is cleaved by β-NAG to release the fluorescent product 4-Methylumbelliferone (4-MU). The reaction is monitored kinetically, with fluorescence measured at an excitation wavelength of 365 nm and emission at 445 nm. The assay offers a linear detection range and is optimized for a 30-minute incubation at 37°C. It can be applied to a wide range of biological samples, including serum, urine, tissue extracts, and cultured cell lysates. Its simplicity and sensitivity make it suitable for both routine laboratory use and high-throughput screening in automated systems.

To ensure consistent results, the assay protocol emphasizes careful timing and thorough mixing during the reaction setup. Standard curves are generated using a series of dilutions to quantify enzyme activity accurately. The assay components include pre-measured substrates, standards, buffers, and positive controls, all stored at -20°C for long-term stability. This standardized kit format ensures reproducibility and efficiency, making it an essential tool for researchers investigating lysosomal enzyme function, biomarker discovery, and disease progression related to glycosphingolipid metabolism.